KR900005657B1 - 1H-이미다조[4,5-c]퀴놀린 화합물및 그것의 제조방법 - Google Patents
1H-이미다조[4,5-c]퀴놀린 화합물및 그것의 제조방법 Download PDFInfo
- Publication number
- KR900005657B1 KR900005657B1 KR1019840007224A KR840007224A KR900005657B1 KR 900005657 B1 KR900005657 B1 KR 900005657B1 KR 1019840007224 A KR1019840007224 A KR 1019840007224A KR 840007224 A KR840007224 A KR 840007224A KR 900005657 B1 KR900005657 B1 KR 900005657B1
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- imidazo
- phenyl
- group
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- -1 1H-imidazo [4,5-c] quinoline compound Chemical class 0.000 title claims description 57
- 238000002360 preparation method Methods 0.000 title description 8
- 150000001875 compounds Chemical class 0.000 claims description 112
- 125000000217 alkyl group Chemical group 0.000 claims description 80
- 238000000034 method Methods 0.000 claims description 71
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 40
- 229910052739 hydrogen Inorganic materials 0.000 claims description 31
- 239000001257 hydrogen Substances 0.000 claims description 31
- 125000003545 alkoxy group Chemical group 0.000 claims description 26
- 229910052799 carbon Inorganic materials 0.000 claims description 22
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 21
- 150000002367 halogens Chemical class 0.000 claims description 20
- 229910052736 halogen Inorganic materials 0.000 claims description 19
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 19
- 239000002253 acid Substances 0.000 claims description 18
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 16
- 150000003839 salts Chemical class 0.000 claims description 16
- 125000004423 acyloxy group Chemical group 0.000 claims description 15
- 125000001424 substituent group Chemical group 0.000 claims description 14
- 150000002431 hydrogen Chemical class 0.000 claims description 13
- FQYRLEXKXQRZDH-UHFFFAOYSA-N 4-aminoquinoline Chemical compound C1=CC=C2C(N)=CC=NC2=C1 FQYRLEXKXQRZDH-UHFFFAOYSA-N 0.000 claims description 8
- 230000000840 anti-viral effect Effects 0.000 claims description 8
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 claims description 8
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 8
- 125000004414 alkyl thio group Chemical group 0.000 claims description 7
- 125000005041 acyloxyalkyl group Chemical group 0.000 claims description 6
- 125000004103 aminoalkyl group Chemical group 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 125000003356 phenylsulfanyl group Chemical group [*]SC1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims description 5
- 125000004663 dialkyl amino group Chemical group 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 238000005576 amination reaction Methods 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- SVNCRRZKBNSMIV-UHFFFAOYSA-N 3-Aminoquinoline Chemical compound C1=CC=CC2=CC(N)=CN=C21 SVNCRRZKBNSMIV-UHFFFAOYSA-N 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000000376 reactant Substances 0.000 claims description 2
- 125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 claims 10
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims 2
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 1
- 230000005494 condensation Effects 0.000 claims 1
- 238000009833 condensation Methods 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 238000007363 ring formation reaction Methods 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 108
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 102
- 238000002844 melting Methods 0.000 description 78
- 230000008018 melting Effects 0.000 description 78
- 239000000203 mixture Substances 0.000 description 72
- 239000007787 solid Substances 0.000 description 67
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 61
- 239000000243 solution Substances 0.000 description 57
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 53
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 50
- 238000004458 analytical method Methods 0.000 description 39
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 33
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 30
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 30
- 238000001953 recrystallisation Methods 0.000 description 30
- 239000000047 product Substances 0.000 description 28
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 27
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 24
- 238000003556 assay Methods 0.000 description 24
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 24
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 23
- 238000001914 filtration Methods 0.000 description 20
- 239000000543 intermediate Substances 0.000 description 20
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 18
- 239000002244 precipitate Substances 0.000 description 17
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 16
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 15
- 238000010992 reflux Methods 0.000 description 15
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 14
- 235000011114 ammonium hydroxide Nutrition 0.000 description 14
- 229960000583 acetic acid Drugs 0.000 description 13
- 239000000908 ammonium hydroxide Substances 0.000 description 13
- RRCWSLBKLVBFQD-UHFFFAOYSA-N 4-chloro-1-(2-methylpropyl)imidazo[4,5-c]quinoline Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(Cl)N=C21 RRCWSLBKLVBFQD-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 12
- 229910021529 ammonia Inorganic materials 0.000 description 11
- RYXSAHOTOCVZEP-UHFFFAOYSA-N 4-chloro-1-methylimidazo[4,5-c]quinoline Chemical compound C1=CC=CC2=C3N(C)C=NC3=C(Cl)N=C21 RYXSAHOTOCVZEP-UHFFFAOYSA-N 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 9
- 239000012362 glacial acetic acid Substances 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 9
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 8
- ZRFUZDDJSQVQBY-UHFFFAOYSA-N 4-chloro-3-nitroquinoline Chemical class C1=CC=CC2=C(Cl)C([N+](=O)[O-])=CN=C21 ZRFUZDDJSQVQBY-UHFFFAOYSA-N 0.000 description 8
- 229940124630 bronchodilator Drugs 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 8
- 230000008020 evaporation Effects 0.000 description 8
- 235000019253 formic acid Nutrition 0.000 description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical compound CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 6
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 6
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 241000700605 Viruses Species 0.000 description 6
- 239000012043 crude product Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- HAAYRLITTXBZOP-UHFFFAOYSA-N n-methyl-3-nitroquinolin-4-amine Chemical compound C1=CC=C2C(NC)=C([N+]([O-])=O)C=NC2=C1 HAAYRLITTXBZOP-UHFFFAOYSA-N 0.000 description 6
- RBKTVDLDAPUNMV-UHFFFAOYSA-N 1-(2-methylpropyl)-5-oxidoimidazo[4,5-c]quinolin-5-ium Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C[N+]([O-])=C21 RBKTVDLDAPUNMV-UHFFFAOYSA-N 0.000 description 5
- UTGXCRCSYKFWCU-UHFFFAOYSA-N 3-(4-chloroimidazo[4,5-c]quinolin-1-yl)propane-1,2-diol Chemical compound C1=CC=CC2=C3N(CC(O)CO)C=NC3=C(Cl)N=C21 UTGXCRCSYKFWCU-UHFFFAOYSA-N 0.000 description 5
- FFWPANGYEXMAAS-UHFFFAOYSA-N 3-imidazo[4,5-c]quinolin-1-ylpropane-1,2-diol Chemical compound C1=CC=CC2=C3N(CC(O)CO)C=NC3=CN=C21 FFWPANGYEXMAAS-UHFFFAOYSA-N 0.000 description 5
- 229910000831 Steel Inorganic materials 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 239000000706 filtrate Substances 0.000 description 5
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 5
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 5
- CDUWBBGUDMBQDE-UHFFFAOYSA-N n-(2-methylpropyl)-3-nitroquinolin-4-amine Chemical compound C1=CC=C2C(NCC(C)C)=C([N+]([O-])=O)C=NC2=C1 CDUWBBGUDMBQDE-UHFFFAOYSA-N 0.000 description 5
- UTOMICFLROGMAE-UHFFFAOYSA-N quinoline-3,4-diamine Chemical compound C1=CC=CC2=C(N)C(N)=CN=C21 UTOMICFLROGMAE-UHFFFAOYSA-N 0.000 description 5
- 150000003248 quinolines Chemical class 0.000 description 5
- 229920006395 saturated elastomer Polymers 0.000 description 5
- 239000010959 steel Substances 0.000 description 5
- NDQXKKFRNOPRDW-UHFFFAOYSA-N 1,1,1-triethoxyethane Chemical compound CCOC(C)(OCC)OCC NDQXKKFRNOPRDW-UHFFFAOYSA-N 0.000 description 4
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 4
- OXRYONUTJMNBIB-UHFFFAOYSA-N 1-(2-methylpropyl)-3h-imidazo[4,5-c]quinoline-2-thione Chemical compound C1=CC=CC2=C3N(CC(C)C)C(S)=NC3=CN=C21 OXRYONUTJMNBIB-UHFFFAOYSA-N 0.000 description 4
- SVFPAVUVBYZGNT-UHFFFAOYSA-N 1-butyl-5-oxidoimidazo[4,5-c]quinolin-5-ium Chemical compound C1=CC=CC2=C3N(CCCC)C=NC3=C[N+]([O-])=C21 SVFPAVUVBYZGNT-UHFFFAOYSA-N 0.000 description 4
- ITIRVXDSMXFTPW-UHFFFAOYSA-N 1H-imidazo[4,5-c]quinoline Chemical group C1=CC=CC2=C(NC=N3)C3=CN=C21 ITIRVXDSMXFTPW-UHFFFAOYSA-N 0.000 description 4
- CPPIRAFONZTAOX-UHFFFAOYSA-N 2-(5-oxidoimidazo[4,5-c]quinolin-5-ium-1-yl)ethyl benzoate Chemical compound C1=2C3=CC=CC=C3[N+]([O-])=CC=2N=CN1CCOC(=O)C1=CC=CC=C1 CPPIRAFONZTAOX-UHFFFAOYSA-N 0.000 description 4
- ZWISCKSGNCMAQO-UHFFFAOYSA-N 3-nitro-1H-quinolin-4-one Chemical compound C1=CC=C2C(=O)C([N+](=O)[O-])=CNC2=C1 ZWISCKSGNCMAQO-UHFFFAOYSA-N 0.000 description 4
- UTVGCDOUIQIJRB-UHFFFAOYSA-N 4-n-(2-phenylethyl)quinoline-3,4-diamine Chemical compound NC1=CN=C2C=CC=CC2=C1NCCC1=CC=CC=C1 UTVGCDOUIQIJRB-UHFFFAOYSA-N 0.000 description 4
- 206010019973 Herpes virus infection Diseases 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 125000003282 alkyl amino group Chemical group 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 4
- 239000003443 antiviral agent Substances 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- VCNBWNGENQSKKZ-UHFFFAOYSA-N 1-(2-methylpropyl)-5h-imidazo[4,5-c]quinolin-4-one Chemical compound C12=CC=CC=C2NC(=O)C2=C1N(CC(C)C)C=N2 VCNBWNGENQSKKZ-UHFFFAOYSA-N 0.000 description 3
- GYQPLQGFPJBAJI-UHFFFAOYSA-N 1-benzyl-4-chloroimidazo[4,5-c]quinoline Chemical compound C1=NC=2C(Cl)=NC3=CC=CC=C3C=2N1CC1=CC=CC=C1 GYQPLQGFPJBAJI-UHFFFAOYSA-N 0.000 description 3
- HKIWBOKRKRFJNV-UHFFFAOYSA-N 2-imidazo[4,5-c]quinolin-1-ylethanol Chemical compound C1=CC=CC2=C3N(CCO)C=NC3=CN=C21 HKIWBOKRKRFJNV-UHFFFAOYSA-N 0.000 description 3
- MUGIDNYZZGALQN-UHFFFAOYSA-N 4-n,6-dimethylquinoline-3,4-diamine;hydrochloride Chemical compound Cl.C1=C(C)C=C2C(NC)=C(N)C=NC2=C1 MUGIDNYZZGALQN-UHFFFAOYSA-N 0.000 description 3
- JFMKIQOIIMSWIM-UHFFFAOYSA-N 4-n-(2-methylpropyl)quinoline-3,4-diamine Chemical compound C1=CC=C2C(NCC(C)C)=C(N)C=NC2=C1 JFMKIQOIIMSWIM-UHFFFAOYSA-N 0.000 description 3
- OLVFQBDCDXUYJW-UHFFFAOYSA-N 8-fluoro-1,4-dimethylimidazo[4,5-c]quinoline Chemical compound CC1=NC2=CC=C(F)C=C2C2=C1N=CN2C OLVFQBDCDXUYJW-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 230000002155 anti-virotic effect Effects 0.000 description 3
- 239000000168 bronchodilator agent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 150000002905 orthoesters Chemical class 0.000 description 3
- 239000007800 oxidant agent Substances 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 3
- UEUKUHMCZKWAFR-UHFFFAOYSA-N (1,8-dimethylimidazo[4,5-c]quinolin-2-yl)methanol Chemical compound C12=CC(C)=CC=C2N=CC2=C1N(C)C(CO)=N2 UEUKUHMCZKWAFR-UHFFFAOYSA-N 0.000 description 2
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 2
- HOOFQGLGAHDHQJ-UHFFFAOYSA-N 1,2-dimethyl-5-oxidoimidazo[4,5-c]quinolin-5-ium Chemical compound C1=CC=CC2=C(N(C(C)=N3)C)C3=C[N+]([O-])=C21 HOOFQGLGAHDHQJ-UHFFFAOYSA-N 0.000 description 2
- KMVGBZBEGFNKOH-UHFFFAOYSA-N 1,2-dimethylimidazo[4,5-c]quinolin-4-amine Chemical compound C1=CC=CC2=C(N(C(C)=N3)C)C3=C(N)N=C21 KMVGBZBEGFNKOH-UHFFFAOYSA-N 0.000 description 2
- OUTIRSSPHAPPPQ-UHFFFAOYSA-N 1,2-dimethylimidazo[4,5-c]quinoline Chemical compound C1=CC=CC2=C(N(C(C)=N3)C)C3=CN=C21 OUTIRSSPHAPPPQ-UHFFFAOYSA-N 0.000 description 2
- CXYOCSTZCULCAE-UHFFFAOYSA-N 1-(2-methylpropyl)imidazo[4,5-c]quinoline Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=CN=C21 CXYOCSTZCULCAE-UHFFFAOYSA-N 0.000 description 2
- QPTQJXFFNOECSP-UHFFFAOYSA-N 1-(4-methoxyphenyl)-5-oxidoimidazo[4,5-c]quinolin-5-ium Chemical compound C1=CC(OC)=CC=C1N1C2=C3C=CC=CC3=[N+]([O-])C=C2N=C1 QPTQJXFFNOECSP-UHFFFAOYSA-N 0.000 description 2
- MGEGWOSWKNESCY-UHFFFAOYSA-N 1-benzyl-2-methylimidazo[4,5-c]quinoline Chemical compound CC1=NC2=CN=C3C=CC=CC3=C2N1CC1=CC=CC=C1 MGEGWOSWKNESCY-UHFFFAOYSA-N 0.000 description 2
- ZPVABWKMDUVERV-UHFFFAOYSA-N 1-benzylimidazo[4,5-c]quinolin-4-amine Chemical compound C1=NC=2C(N)=NC3=CC=CC=C3C=2N1CC1=CC=CC=C1 ZPVABWKMDUVERV-UHFFFAOYSA-N 0.000 description 2
- DCKJKIURDIVCPL-UHFFFAOYSA-N 1-ethyl-2-methylimidazo[4,5-c]quinoline Chemical compound C1=CC=CC2=C3N(CC)C(C)=NC3=CN=C21 DCKJKIURDIVCPL-UHFFFAOYSA-N 0.000 description 2
- QXFFVNLCGVMACD-UHFFFAOYSA-N 1-methyl-3h-imidazo[4,5-c]quinoline-2-thione Chemical compound C1=CC=CC2=C3N(C)C(S)=NC3=CN=C21 QXFFVNLCGVMACD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- OWKZMVASJFEUKK-UHFFFAOYSA-N 2-(4-aminoimidazo[4,5-c]quinolin-1-yl)ethanol Chemical compound NC1=NC2=CC=CC=C2C2=C1N=CN2CCO OWKZMVASJFEUKK-UHFFFAOYSA-N 0.000 description 2
- IMMRAUSHGRKQLO-UHFFFAOYSA-N 2-(4-chloroimidazo[4,5-c]quinolin-1-yl)ethyl benzoate Chemical compound C1=NC=2C(Cl)=NC3=CC=CC=C3C=2N1CCOC(=O)C1=CC=CC=C1 IMMRAUSHGRKQLO-UHFFFAOYSA-N 0.000 description 2
- IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 2
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 2
- DCKDJXAYJHREKA-UHFFFAOYSA-N 2-imidazo[4,5-c]quinolin-1-ylethyl benzoate Chemical compound C1=NC2=CN=C3C=CC=CC3=C2N1CCOC(=O)C1=CC=CC=C1 DCKDJXAYJHREKA-UHFFFAOYSA-N 0.000 description 2
- MDLMJOMTZXNMDY-UHFFFAOYSA-N 3-(2-methylimidazo[4,5-c]quinolin-1-yl)propane-1,2-diol Chemical compound C1=CC=CC2=C(N(C(C)=N3)CC(O)CO)C3=CN=C21 MDLMJOMTZXNMDY-UHFFFAOYSA-N 0.000 description 2
- FVSWUEXWBPNFKW-UHFFFAOYSA-N 3-(4-chloro-2-methylimidazo[4,5-c]quinolin-1-yl)propane-1,2-diol Chemical compound C1=CC=CC2=C(N(C(C)=N3)CC(O)CO)C3=C(Cl)N=C21 FVSWUEXWBPNFKW-UHFFFAOYSA-N 0.000 description 2
- SGMJLOCCQHCXSL-UHFFFAOYSA-N 3-[(3-amino-6-fluoro-2-methylquinolin-4-yl)amino]propane-1,2-diol Chemical compound C1=C(F)C=C2C(NCC(O)CO)=C(N)C(C)=NC2=C1 SGMJLOCCQHCXSL-UHFFFAOYSA-N 0.000 description 2
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 2
- GAJIIIXBMNRWIX-UHFFFAOYSA-N 4-chloro-1,2-dimethylimidazo[4,5-c]quinoline Chemical compound C1=CC=CC2=C(N(C(C)=N3)C)C3=C(Cl)N=C21 GAJIIIXBMNRWIX-UHFFFAOYSA-N 0.000 description 2
- XPYLASDQZHCVHA-UHFFFAOYSA-N 4-chloro-1-(4-methoxyphenyl)imidazo[4,5-c]quinoline Chemical compound C1=CC(OC)=CC=C1N1C2=C3C=CC=CC3=NC(Cl)=C2N=C1 XPYLASDQZHCVHA-UHFFFAOYSA-N 0.000 description 2
- KTASVNZVTGKHMY-UHFFFAOYSA-N 4-chloro-1-(cyclohexylmethyl)imidazo[4,5-c]quinoline Chemical compound C1=NC=2C(Cl)=NC3=CC=CC=C3C=2N1CC1CCCCC1 KTASVNZVTGKHMY-UHFFFAOYSA-N 0.000 description 2
- ORTUUVWVDUZYNS-UHFFFAOYSA-N 4-methoxy-1-methylimidazo[4,5-c]quinoline Chemical compound COC1=NC2=CC=CC=C2C2=C1N=CN2C ORTUUVWVDUZYNS-UHFFFAOYSA-N 0.000 description 2
- NBCMDJKAZWDEKE-UHFFFAOYSA-N 4-n-[2-(dimethylamino)ethyl]quinoline-3,4-diamine Chemical compound C1=CC=C2C(NCCN(C)C)=C(N)C=NC2=C1 NBCMDJKAZWDEKE-UHFFFAOYSA-N 0.000 description 2
- HKGPTTMXHQAEBO-UHFFFAOYSA-N 4-n-benzylquinoline-3,4-diamine Chemical compound NC1=CN=C2C=CC=CC2=C1NCC1=CC=CC=C1 HKGPTTMXHQAEBO-UHFFFAOYSA-N 0.000 description 2
- OGAYBYZECXWINC-UHFFFAOYSA-N 4-n-methylquinoline-3,4-diamine Chemical compound C1=CC=C2C(NC)=C(N)C=NC2=C1 OGAYBYZECXWINC-UHFFFAOYSA-N 0.000 description 2
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 2
- ABJPLNIQTZSCCY-UHFFFAOYSA-N 6-fluoro-2-methylquinoline-3,4-diamine Chemical compound C1=C(F)C=C2C(N)=C(N)C(C)=NC2=C1 ABJPLNIQTZSCCY-UHFFFAOYSA-N 0.000 description 2
- YAQWLVRCZOQDFX-UHFFFAOYSA-N 6-fluoro-4-n,2-dimethylquinoline-3,4-diamine Chemical compound C1=C(F)C=C2C(NC)=C(N)C(C)=NC2=C1 YAQWLVRCZOQDFX-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 2
- 241000701074 Human alphaherpesvirus 2 Species 0.000 description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 150000001204 N-oxides Chemical class 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 239000003430 antimalarial agent Substances 0.000 description 2
- 238000010533 azeotropic distillation Methods 0.000 description 2
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 2
- 229910001626 barium chloride Inorganic materials 0.000 description 2
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000012320 chlorinating reagent Substances 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 125000005265 dialkylamine group Chemical group 0.000 description 2
- IRUNKQSGDBYUDC-UHFFFAOYSA-N diethoxymethyl acetate Chemical compound CCOC(OCC)OC(C)=O IRUNKQSGDBYUDC-UHFFFAOYSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- NSHFLKZNBPJNPA-UHFFFAOYSA-N imidazo[4,5-c]quinolin-2-one Chemical class C1=CC=C2C3=NC(=O)N=C3C=NC2=C1 NSHFLKZNBPJNPA-UHFFFAOYSA-N 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229960002216 methylparaben Drugs 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- MUAJFJPQRJVLQC-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-3-nitroquinolin-4-amine Chemical compound [O-][N+](=O)C1=CN=C2C=CC=CC2=C1NCC1=CC=C(Cl)C=C1 MUAJFJPQRJVLQC-UHFFFAOYSA-N 0.000 description 2
- LOOLNLMGAXKIJT-UHFFFAOYSA-N n-benzyl-3-nitroquinolin-4-amine Chemical compound [O-][N+](=O)C1=CN=C2C=CC=CC2=C1NCC1=CC=CC=C1 LOOLNLMGAXKIJT-UHFFFAOYSA-N 0.000 description 2
- DYOMJTFYBZLFLL-UHFFFAOYSA-N n-butyl-1-methylimidazo[4,5-c]quinolin-4-amine Chemical compound CCCCNC1=NC2=CC=CC=C2C2=C1N=CN2C DYOMJTFYBZLFLL-UHFFFAOYSA-N 0.000 description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 2
- DNEZXDBGRSLNMK-UHFFFAOYSA-N n-hexyl-3-nitroquinolin-4-amine Chemical compound C1=CC=C2C(NCCCCCC)=C([N+]([O-])=O)C=NC2=C1 DNEZXDBGRSLNMK-UHFFFAOYSA-N 0.000 description 2
- GSWAOPJLTADLTN-UHFFFAOYSA-N oxidanimine Chemical compound [O-][NH3+] GSWAOPJLTADLTN-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 2
- 229960003415 propylparaben Drugs 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- GNZIHPAAJVXCAS-UHFFFAOYSA-N quinolin-4-amine;hydrochloride Chemical compound Cl.C1=CC=C2C(N)=CC=NC2=C1 GNZIHPAAJVXCAS-UHFFFAOYSA-N 0.000 description 2
- 238000002390 rotary evaporation Methods 0.000 description 2
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000012265 solid product Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- AULYEXBWAWTPNX-UHFFFAOYSA-N (1,8-dimethylimidazo[4,5-c]quinolin-2-yl)methanol;hydrate;hydrochloride Chemical compound O.Cl.C12=CC(C)=CC=C2N=CC2=C1N(C)C(CO)=N2 AULYEXBWAWTPNX-UHFFFAOYSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- CIUCPFYCCFDARX-UHFFFAOYSA-N 1,2,8-trimethylimidazo[4,5-c]quinolin-4-amine Chemical compound C1=CC(C)=CC2=C(N(C(C)=N3)C)C3=C(N)N=C21 CIUCPFYCCFDARX-UHFFFAOYSA-N 0.000 description 1
- GHJJOJMPJWBBIV-UHFFFAOYSA-N 1,2,8-trimethylimidazo[4,5-c]quinoline Chemical compound C1=CC(C)=CC2=C(N(C(C)=N3)C)C3=CN=C21 GHJJOJMPJWBBIV-UHFFFAOYSA-N 0.000 description 1
- OXQYLLCZYJLWLZ-UHFFFAOYSA-N 1,8-dimethyl-2-(trifluoromethyl)imidazo[4,5-c]quinoline Chemical compound C12=CC(C)=CC=C2N=CC2=C1N(C)C(C(F)(F)F)=N2 OXQYLLCZYJLWLZ-UHFFFAOYSA-N 0.000 description 1
- AWQMGZVGZJHOIL-UHFFFAOYSA-N 1,8-dimethylimidazo[4,5-c]quinoline Chemical compound C12=CC(C)=CC=C2N=CC2=C1N(C)C=N2 AWQMGZVGZJHOIL-UHFFFAOYSA-N 0.000 description 1
- RTKMBBVNZAQLLQ-UHFFFAOYSA-N 1-(2,3-dihydroxypropyl)-5h-imidazo[4,5-c]quinolin-4-one;hydrate Chemical compound O.C1=CC=CC2=C3N(CC(O)CO)C=NC3=C(O)N=C21 RTKMBBVNZAQLLQ-UHFFFAOYSA-N 0.000 description 1
- JORYIRGISQHJHV-UHFFFAOYSA-N 1-(2-hydroxyethyl)-5h-imidazo[4,5-c]quinolin-4-one Chemical compound C1=CC=CC2=C3N(CCO)C=NC3=C(O)N=C21 JORYIRGISQHJHV-UHFFFAOYSA-N 0.000 description 1
- JFZZLKAPHACSTR-UHFFFAOYSA-N 1-(2-methylpropyl)-2-methylsulfanylimidazo[4,5-c]quinoline;hydrochloride Chemical compound Cl.C1=CC=CC2=C(N(C(SC)=N3)CC(C)C)C3=CN=C21 JFZZLKAPHACSTR-UHFFFAOYSA-N 0.000 description 1
- UPWLUKSXOGEUTD-UHFFFAOYSA-N 1-(2-methylpropyl)imidazo[4,5-c]quinoline;hydrate;hydrochloride Chemical compound O.Cl.C1=CC=CC2=C3N(CC(C)C)C=NC3=CN=C21 UPWLUKSXOGEUTD-UHFFFAOYSA-N 0.000 description 1
- VOXGMWWBNKROGE-UHFFFAOYSA-N 1-(2-phenylethyl)imidazo[4,5-c]quinoline Chemical compound C1=NC2=CN=C3C=CC=CC3=C2N1CCC1=CC=CC=C1 VOXGMWWBNKROGE-UHFFFAOYSA-N 0.000 description 1
- LWDWBGPVIQOHBG-UHFFFAOYSA-N 1-(4-fluorophenyl)imidazo[4,5-c]quinoline Chemical compound C1=CC(F)=CC=C1N1C2=C3C=CC=CC3=NC=C2N=C1 LWDWBGPVIQOHBG-UHFFFAOYSA-N 0.000 description 1
- VRBZCCKKBQXQOV-UHFFFAOYSA-N 1-(4-methoxyphenyl)-5h-imidazo[4,5-c]quinolin-4-one Chemical compound C1=CC(OC)=CC=C1N1C2=C3C=CC=CC3=NC(O)=C2N=C1 VRBZCCKKBQXQOV-UHFFFAOYSA-N 0.000 description 1
- FWYDWMFOMXRKFS-UHFFFAOYSA-N 1-[(4-chlorophenyl)methyl]-2-methylimidazo[4,5-c]quinoline Chemical compound CC1=NC2=CN=C3C=CC=CC3=C2N1CC1=CC=C(Cl)C=C1 FWYDWMFOMXRKFS-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- YACAXCTYWPGMSJ-UHFFFAOYSA-N 1-benzyl-2-methylimidazo[4,5-c]quinolin-4-amine Chemical compound CC1=NC2=C(N)N=C3C=CC=CC3=C2N1CC1=CC=CC=C1 YACAXCTYWPGMSJ-UHFFFAOYSA-N 0.000 description 1
- FQGMQMXUMHGBTB-UHFFFAOYSA-N 1-benzyl-2-methylimidazo[4,5-c]quinoline;hydrate Chemical compound O.CC1=NC2=CN=C3C=CC=CC3=C2N1CC1=CC=CC=C1 FQGMQMXUMHGBTB-UHFFFAOYSA-N 0.000 description 1
- ZKHWWGYSQLYDBY-UHFFFAOYSA-N 1-ethylimidazo[4,5-c]quinoline Chemical compound C1=CC=CC2=C3N(CC)C=NC3=CN=C21 ZKHWWGYSQLYDBY-UHFFFAOYSA-N 0.000 description 1
- KKRHABVBDRJBCX-UHFFFAOYSA-N 1-hexyl-5-oxidoimidazo[4,5-c]quinolin-5-ium Chemical compound C1=CC=CC2=C3N(CCCCCC)C=NC3=C[N+]([O-])=C21 KKRHABVBDRJBCX-UHFFFAOYSA-N 0.000 description 1
- DLYGXXQXTFQBSA-UHFFFAOYSA-N 1-hexylimidazo[4,5-c]quinolin-4-amine Chemical compound C1=CC=CC2=C3N(CCCCCC)C=NC3=C(N)N=C21 DLYGXXQXTFQBSA-UHFFFAOYSA-N 0.000 description 1
- IZKNXNLGYNRZHM-UHFFFAOYSA-N 1-hexylimidazo[4,5-c]quinoline Chemical compound C1=CC=CC2=C3N(CCCCCC)C=NC3=CN=C21 IZKNXNLGYNRZHM-UHFFFAOYSA-N 0.000 description 1
- WXYHLJSBJOCSHH-UHFFFAOYSA-N 1-methyl-2-propan-2-ylimidazo[4,5-c]quinoline Chemical compound C1=CC=CC2=C(N(C(C(C)C)=N3)C)C3=CN=C21 WXYHLJSBJOCSHH-UHFFFAOYSA-N 0.000 description 1
- HDXDWDLYJOMUJY-UHFFFAOYSA-N 1-methyl-2-propan-2-ylimidazo[4,5-c]quinoline;hydrochloride Chemical compound Cl.C1=CC=CC2=C(N(C(C(C)C)=N3)C)C3=CN=C21 HDXDWDLYJOMUJY-UHFFFAOYSA-N 0.000 description 1
- GXGGYIZUTIETJA-UHFFFAOYSA-N 1-methyl-4-phenylsulfanylimidazo[4,5-c]quinoline Chemical compound N1=C2C=CC=CC2=C2N(C)C=NC2=C1SC1=CC=CC=C1 GXGGYIZUTIETJA-UHFFFAOYSA-N 0.000 description 1
- PDEJNVGATHPZFX-UHFFFAOYSA-N 1-methylimidazo[4,5-c]quinolin-4-amine Chemical compound C1=CC=CC2=C3N(C)C=NC3=C(N)N=C21 PDEJNVGATHPZFX-UHFFFAOYSA-N 0.000 description 1
- MBEOKCONJLQHKT-UHFFFAOYSA-N 1-methylimidazo[4,5-c]quinoline Chemical compound C1=CC=CC2=C3N(C)C=NC3=CN=C21 MBEOKCONJLQHKT-UHFFFAOYSA-N 0.000 description 1
- GJYOPPSKPPTEMK-UHFFFAOYSA-N 1-phenylimidazo[4,5-c]quinoline Chemical compound C1=NC2=CN=C3C=CC=CC3=C2N1C1=CC=CC=C1 GJYOPPSKPPTEMK-UHFFFAOYSA-N 0.000 description 1
- JZXGYDHXMPGSKT-UHFFFAOYSA-N 2,4-dimethyl-3h-imidazo[4,5-c]quinoline Chemical compound C1=CC=CC2=C(NC(C)=N3)C3=C(C)N=C21 JZXGYDHXMPGSKT-UHFFFAOYSA-N 0.000 description 1
- CSEWAUGPAQPMDC-UHFFFAOYSA-N 2-(4-aminophenyl)acetic acid Chemical compound NC1=CC=C(CC(O)=O)C=C1 CSEWAUGPAQPMDC-UHFFFAOYSA-N 0.000 description 1
- VMLJQFROKYEXBG-UHFFFAOYSA-N 2-(4-chloroimidazo[4,5-c]quinolin-1-yl)ethanol Chemical compound C1=CC=CC2=C3N(CCO)C=NC3=C(Cl)N=C21 VMLJQFROKYEXBG-UHFFFAOYSA-N 0.000 description 1
- IRSVEUYCNDTKSL-UHFFFAOYSA-N 2-(4-imidazo[4,5-c]quinolin-1-ylphenyl)acetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1N1C2=C3C=CC=CC3=NC=C2N=C1 IRSVEUYCNDTKSL-UHFFFAOYSA-N 0.000 description 1
- HFVRFNRLDPQPHN-UHFFFAOYSA-N 2-[4-[(3-aminoquinolin-4-yl)amino]phenyl]acetic acid Chemical compound NC1=CN=C2C=CC=CC2=C1NC1=CC=C(CC(O)=O)C=C1 HFVRFNRLDPQPHN-UHFFFAOYSA-N 0.000 description 1
- USYNIJINWCTMTF-UHFFFAOYSA-N 2-benzylsulfanyl-1-methylimidazo[4,5-c]quinoline Chemical compound N=1C2=CN=C3C=CC=CC3=C2N(C)C=1SCC1=CC=CC=C1 USYNIJINWCTMTF-UHFFFAOYSA-N 0.000 description 1
- VVWCQEUVFCZDKY-UHFFFAOYSA-N 2-imidazo[4,5-c]quinolin-1-yl-n,n-dimethylethanamine Chemical compound C1=CC=CC2=C3N(CCN(C)C)C=NC3=CN=C21 VVWCQEUVFCZDKY-UHFFFAOYSA-N 0.000 description 1
- UKTIXLHPBUKBFH-UHFFFAOYSA-N 2-imidazo[4,5-c]quinolin-1-yl-n,n-dimethylethanamine;hydrate;trihydrochloride Chemical compound O.Cl.Cl.Cl.C1=CC=CC2=C3N(CCN(C)C)C=NC3=CN=C21 UKTIXLHPBUKBFH-UHFFFAOYSA-N 0.000 description 1
- PWAWKIVQAKJUHS-UHFFFAOYSA-N 2-methyl-1-(2-phenylethyl)imidazo[4,5-c]quinolin-4-amine Chemical compound CC1=NC2=C(N)N=C3C=CC=CC3=C2N1CCC1=CC=CC=C1 PWAWKIVQAKJUHS-UHFFFAOYSA-N 0.000 description 1
- PGYKMCXTVBDWHM-UHFFFAOYSA-N 2-methyl-1-(2-phenylethyl)imidazo[4,5-c]quinoline Chemical compound CC1=NC2=CN=C3C=CC=CC3=C2N1CCC1=CC=CC=C1 PGYKMCXTVBDWHM-UHFFFAOYSA-N 0.000 description 1
- JEMURESLEMCBKE-UHFFFAOYSA-N 3-(1,8-dimethylimidazo[4,5-c]quinolin-2-yl)propan-1-amine Chemical compound C12=CC(C)=CC=C2N=CC2=C1N(C)C(CCCN)=N2 JEMURESLEMCBKE-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- ZFOARTLYRZYDQD-UHFFFAOYSA-N 3-(4-methoxyimidazo[4,5-c]quinolin-1-yl)propane-1,2-diol Chemical compound COC1=NC2=CC=CC=C2C2=C1N=CN2CC(O)CO ZFOARTLYRZYDQD-UHFFFAOYSA-N 0.000 description 1
- HLCMKOLVTBKDJA-UHFFFAOYSA-N 3-(5-oxidoimidazo[4,5-c]quinolin-5-ium-1-yl)propane-1,2-diol Chemical compound C1=CC=CC2=C3N(CC(O)CO)C=NC3=C[N+]([O-])=C21 HLCMKOLVTBKDJA-UHFFFAOYSA-N 0.000 description 1
- IZNRRVZXENGGDF-UHFFFAOYSA-N 3-(8-fluoro-4-methylimidazo[4,5-c]quinolin-1-yl)propane-1,2-diol;hydrate Chemical compound O.CC1=NC2=CC=C(F)C=C2C2=C1N=CN2CC(O)CO IZNRRVZXENGGDF-UHFFFAOYSA-N 0.000 description 1
- YYFLDZZDOUDZQM-UHFFFAOYSA-N 3-[1-[[4-(3-phenylquinolin-2-yl)phenyl]methyl]piperidin-4-yl]-1h-benzimidazol-2-one Chemical compound O=C1NC2=CC=CC=C2N1C(CC1)CCN1CC(C=C1)=CC=C1C1=NC2=CC=CC=C2C=C1C1=CC=CC=C1 YYFLDZZDOUDZQM-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- UQOVJXAVTPEGAB-UHFFFAOYSA-N 3-[4-(methylamino)imidazo[4,5-c]quinolin-1-yl]propane-1,2-diol Chemical compound CNC1=NC2=CC=CC=C2C2=C1N=CN2CC(O)CO UQOVJXAVTPEGAB-UHFFFAOYSA-N 0.000 description 1
- QTRYLIQMGIDOBS-UHFFFAOYSA-N 3H-imidazo[4,5-c]quinoline hydrate Chemical compound O.C1=CC=CC2=C(NC=N3)C3=CN=C21 QTRYLIQMGIDOBS-UHFFFAOYSA-N 0.000 description 1
- HQBUPOAKJGJGCD-UHFFFAOYSA-N 3h-imidazo[4,5-c]quinolin-4-amine Chemical compound NC1=NC2=CC=CC=C2C2=C1N=CN2 HQBUPOAKJGJGCD-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- GRQACZPLYRKJFT-UHFFFAOYSA-N 4-cyclohexyl-N-methyl-3-nitroquinolin-2-amine Chemical compound C1(CCCCC1)C1=C(C(=NC2=CC=CC=C12)NC)[N+](=O)[O-] GRQACZPLYRKJFT-UHFFFAOYSA-N 0.000 description 1
- XKTDOADAZBEOHL-UHFFFAOYSA-N 4-methoxy-1-(2-methylpropyl)imidazo[4,5-c]quinoline Chemical compound COC1=NC2=CC=CC=C2C2=C1N=CN2CC(C)C XKTDOADAZBEOHL-UHFFFAOYSA-N 0.000 description 1
- LEHXHVSIQZRRGZ-UHFFFAOYSA-N 4-methoxy-1-(4-methoxyphenyl)imidazo[4,5-c]quinoline Chemical compound C1=CC(OC)=CC=C1N1C2=C3C=CC=CC3=NC(OC)=C2N=C1 LEHXHVSIQZRRGZ-UHFFFAOYSA-N 0.000 description 1
- QAHHBCJMFQXXCO-UHFFFAOYSA-N 4-methyl-3h-imidazo[4,5-c]quinoline Chemical compound CC1=NC2=CC=CC=C2C2=C1N=CN2 QAHHBCJMFQXXCO-UHFFFAOYSA-N 0.000 description 1
- BSYVEAXYOVBLSZ-UHFFFAOYSA-N 4-n,6-dimethylquinoline-3,4-diamine Chemical compound C1=C(C)C=C2C(NC)=C(N)C=NC2=C1 BSYVEAXYOVBLSZ-UHFFFAOYSA-N 0.000 description 1
- NARMRWUULYDZIS-UHFFFAOYSA-N 4-n-(cyclohexylmethyl)quinoline-3,4-diamine Chemical compound NC1=CN=C2C=CC=CC2=C1NCC1CCCCC1 NARMRWUULYDZIS-UHFFFAOYSA-N 0.000 description 1
- HFNMRNNHASNHGR-UHFFFAOYSA-N 4-n-[(4-chlorophenyl)methyl]quinoline-3,4-diamine Chemical compound NC1=CN=C2C=CC=CC2=C1NCC1=CC=C(Cl)C=C1 HFNMRNNHASNHGR-UHFFFAOYSA-N 0.000 description 1
- MLUXQSRULOUMJF-UHFFFAOYSA-N 4-nitroquinolin-3-ol Chemical compound C1=CC=CC2=C([N+]([O-])=O)C(O)=CN=C21 MLUXQSRULOUMJF-UHFFFAOYSA-N 0.000 description 1
- BEHJAKZNXDMWMP-UHFFFAOYSA-N 6,7-dimethoxy-n-(2-methylpropyl)-3-nitroquinolin-4-amine Chemical compound C1=C([N+]([O-])=O)C(NCC(C)C)=C2C=C(OC)C(OC)=CC2=N1 BEHJAKZNXDMWMP-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- UUIVFOSKOKVTLC-UHFFFAOYSA-N 8-fluoro-1,4-dimethyl-5-oxidoimidazo[4,5-c]quinolin-5-ium Chemical compound CC1=[N+]([O-])C2=CC=C(F)C=C2C2=C1N=CN2C UUIVFOSKOKVTLC-UHFFFAOYSA-N 0.000 description 1
- FWODWYMGLMPKEQ-UHFFFAOYSA-N 8-fluoro-4-methyl-3h-imidazo[4,5-c]quinoline;hydrate Chemical compound O.CC1=NC2=CC=C(F)C=C2C2=C1N=CN2 FWODWYMGLMPKEQ-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- KQJQICVXLJTWQD-UHFFFAOYSA-N N-Methylthiourea Chemical compound CNC(N)=S KQJQICVXLJTWQD-UHFFFAOYSA-N 0.000 description 1
- XTUVJUMINZSXGF-UHFFFAOYSA-N N-methylcyclohexylamine Chemical compound CNC1CCCCC1 XTUVJUMINZSXGF-UHFFFAOYSA-N 0.000 description 1
- YMTZBQWEOCQBQN-UHFFFAOYSA-N NC=1C(=NC2=CC=CC=C2C1CCCCCC)N Chemical group NC=1C(=NC2=CC=CC=C2C1CCCCCC)N YMTZBQWEOCQBQN-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 1
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- TYZBOEXFWYFXDC-UHFFFAOYSA-N [2-acetyloxy-3-(5-oxidoimidazo[4,5-c]quinolin-5-ium-1-yl)propyl] acetate Chemical compound C1=CC=CC2=C3N(CC(COC(=O)C)OC(C)=O)C=NC3=C[N+]([O-])=C21 TYZBOEXFWYFXDC-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000000078 anti-malarial effect Effects 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 238000005574 benzylation reaction Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000006184 cosolvent Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000004983 dialkoxyalkyl group Chemical group 0.000 description 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- OKBPCTLSPGDQBO-UHFFFAOYSA-L disodium;dichloride Chemical compound [Na+].[Na+].[Cl-].[Cl-] OKBPCTLSPGDQBO-UHFFFAOYSA-L 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000007580 dry-mixing Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- QFXZANXYUCUTQH-UHFFFAOYSA-N ethynol Chemical compound OC#C QFXZANXYUCUTQH-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 244000177546 frostweed Species 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229940074045 glyceryl distearate Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- FUKUFMFMCZIRNT-UHFFFAOYSA-N hydron;methanol;chloride Chemical compound Cl.OC FUKUFMFMCZIRNT-UHFFFAOYSA-N 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- LRPCLTPZMUIPFK-UHFFFAOYSA-N methane;sulfuric acid Chemical compound C.OS(O)(=O)=O LRPCLTPZMUIPFK-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- BBNDUQTXFXXISR-UHFFFAOYSA-N methanesulfonic acid;2-methyl-1-(2-phenylethyl)imidazo[4,5-c]quinolin-4-amine Chemical compound CS(O)(=O)=O.CC1=NC2=C(N)N=C3C=CC=CC3=C2N1CCC1=CC=CC=C1 BBNDUQTXFXXISR-UHFFFAOYSA-N 0.000 description 1
- RFKMCNOHBTXSMU-UHFFFAOYSA-N methoxyflurane Chemical compound COC(F)(F)C(Cl)Cl RFKMCNOHBTXSMU-UHFFFAOYSA-N 0.000 description 1
- 229960002455 methoxyflurane Drugs 0.000 description 1
- MQDPDLNTBMDLHF-UHFFFAOYSA-N methyl n-(3h-imidazo[4,5-c]quinolin-2-yl)carbamate;hydrate Chemical compound O.C1=CC=C2C(N=C(N3)NC(=O)OC)=C3C=NC2=C1 MQDPDLNTBMDLHF-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- IYBNMIAQTRAYKI-UHFFFAOYSA-N n,1-dimethylimidazo[4,5-c]quinolin-4-amine Chemical compound CNC1=NC2=CC=CC=C2C2=C1N=CN2C IYBNMIAQTRAYKI-UHFFFAOYSA-N 0.000 description 1
- PUABDCPWRNRLQN-UHFFFAOYSA-N n-(2-methylpropyl)quinolin-2-amine Chemical compound C1=CC=CC2=NC(NCC(C)C)=CC=C21 PUABDCPWRNRLQN-UHFFFAOYSA-N 0.000 description 1
- QDNIOEOWSDCXFB-UHFFFAOYSA-N n-(2-phenylethyl)imidazo[4,5-c]quinolin-1-amine Chemical compound C1=NC2=CN=C3C=CC=CC3=C2N1NCCC1=CC=CC=C1 QDNIOEOWSDCXFB-UHFFFAOYSA-N 0.000 description 1
- SDCYKYSQHYSGFR-UHFFFAOYSA-N n-[3-(1,8-dimethylimidazo[4,5-c]quinolin-2-yl)propyl]acetamide Chemical compound C1=CC(C)=CC2=C(N(C(CCCNC(=O)C)=N3)C)C3=CN=C21 SDCYKYSQHYSGFR-UHFFFAOYSA-N 0.000 description 1
- XCVNDBIXFPGMIW-UHFFFAOYSA-N n-ethylpropan-1-amine Chemical compound CCCNCC XCVNDBIXFPGMIW-UHFFFAOYSA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 150000004965 peroxy acids Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- FFUQCRZBKUBHQT-UHFFFAOYSA-N phosphoryl fluoride Chemical compound FP(F)(F)=O FFUQCRZBKUBHQT-UHFFFAOYSA-N 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- BTUQCUPQFZHMNS-UHFFFAOYSA-N quinoline;dihydrochloride Chemical compound Cl.Cl.N1=CC=CC2=CC=CC=C21 BTUQCUPQFZHMNS-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical group 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- XMVJITFPVVRMHC-UHFFFAOYSA-N roxarsone Chemical group OC1=CC=C([As](O)(O)=O)C=C1[N+]([O-])=O XMVJITFPVVRMHC-UHFFFAOYSA-N 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- IMCGHZIGRANKHV-AJNGGQMLSA-N tert-butyl (3s,5s)-2-oxo-5-[(2s,4s)-5-oxo-4-propan-2-yloxolan-2-yl]-3-propan-2-ylpyrrolidine-1-carboxylate Chemical compound O1C(=O)[C@H](C(C)C)C[C@H]1[C@H]1N(C(=O)OC(C)(C)C)C(=O)[C@H](C(C)C)C1 IMCGHZIGRANKHV-AJNGGQMLSA-N 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Physical Water Treatments (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Alarm Systems (AREA)
- Quinoline Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Lubricants (AREA)
- Luminescent Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55315883A | 1983-11-18 | 1983-11-18 | |
| US55315783A | 1983-11-18 | 1983-11-18 | |
| US553158 | 1983-11-18 | ||
| US553157 | 1983-11-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR850003890A KR850003890A (ko) | 1985-06-29 |
| KR900005657B1 true KR900005657B1 (ko) | 1990-08-03 |
Family
ID=27070262
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019840007224A Expired KR900005657B1 (ko) | 1983-11-18 | 1984-11-17 | 1H-이미다조[4,5-c]퀴놀린 화합물및 그것의 제조방법 |
Country Status (15)
| Country | Link |
|---|---|
| EP (2) | EP0310950B1 (https=) |
| JP (1) | JPS60123488A (https=) |
| KR (1) | KR900005657B1 (https=) |
| AT (2) | ATE49763T1 (https=) |
| AU (2) | AU581190B2 (https=) |
| CA (1) | CA1271477A (https=) |
| DE (3) | DE19975027I2 (https=) |
| DK (6) | DK164280C (https=) |
| ES (1) | ES537677A0 (https=) |
| IE (1) | IE57874B1 (https=) |
| IL (2) | IL84537A (https=) |
| NL (2) | NL980041I2 (https=) |
| NO (7) | NO163819C (https=) |
| NZ (1) | NZ210228A (https=) |
| PH (1) | PH22338A (https=) |
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1306260C (en) | 1985-10-18 | 1992-08-11 | Shionogi & Co., Ltd. | Condensed imidazopyridine derivatives |
| US4942168A (en) * | 1987-07-13 | 1990-07-17 | Hoechst-Roussel Pharmaceuticals Inc. | Hydroxyquinoline amines, and method of enhancing memory in mammals |
| CA1335996C (en) * | 1988-02-16 | 1995-06-20 | Susumu Takada | 2-substituted carbonylimidazo¬4,5-c|quinolines |
| US5019574A (en) * | 1988-09-30 | 1991-05-28 | Chugai Seiyaku Kabushiki Kaisha | 3,4-diaminoquinoline and 3,4-diamino-5,6,7,8-tetrahydroquinoline compounds useful for improving psychoneural function |
| EP0385630B1 (en) * | 1989-02-27 | 1996-11-27 | Riker Laboratories, Inc. | 1H-imidazo(4,5-c)Quinolin-4-amines as antivirals |
| CA2011504C (en) * | 1989-03-07 | 1998-06-02 | Kenji Ohmori | Imidazoquinolone derivatives |
| US4929624A (en) * | 1989-03-23 | 1990-05-29 | Minnesota Mining And Manufacturing Company | Olefinic 1H-imidazo(4,5-c)quinolin-4-amines |
| CA2021338C (en) * | 1989-07-18 | 1996-07-16 | Fumio Suzuki | Imidazoquinolone derivatives |
| US4988815A (en) * | 1989-10-26 | 1991-01-29 | Riker Laboratories, Inc. | 3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines |
| FR2654021B1 (fr) * | 1989-11-07 | 1992-02-28 | Simond Jacques | Procede de vitrification de cendres volantes et dispositif pour sa mise en óoeuvre. |
| GB8928281D0 (en) * | 1989-12-14 | 1990-02-21 | Smith Kline French Lab | Compounds |
| ES2094772T3 (es) * | 1990-06-01 | 1997-02-01 | Kyowa Hakko Kogyo Kk | Derivados de imidazonaftiridinas. |
| DE69229114T2 (de) * | 1991-03-01 | 1999-11-04 | Minnesota Mining And Mfg. Co., Saint Paul | 1,2-substituierte 1h-imidazo[4,5-c]chinolin-4-amine |
| US5266575A (en) * | 1991-11-06 | 1993-11-30 | Minnesota Mining And Manufacturing Company | 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines |
| IL105325A (en) * | 1992-04-16 | 1996-11-14 | Minnesota Mining & Mfg | Immunogen/vaccine adjuvant composition |
| US5395937A (en) * | 1993-01-29 | 1995-03-07 | Minnesota Mining And Manufacturing Company | Process for preparing quinoline amines |
| US5693811A (en) * | 1996-06-21 | 1997-12-02 | Minnesota Mining And Manufacturing Company | Process for preparing tetrahdroimidazoquinolinamines |
| US6069149A (en) * | 1997-01-09 | 2000-05-30 | Terumo Kabushiki Kaisha | Amide derivatives and intermediates for the synthesis thereof |
| JPH10298181A (ja) * | 1997-04-25 | 1998-11-10 | Sumitomo Pharmaceut Co Ltd | タイプ２ヘルパーｔ細胞選択的免疫応答抑制剤 |
| JP2000119271A (ja) * | 1998-08-12 | 2000-04-25 | Hokuriku Seiyaku Co Ltd | １ｈ―イミダゾピリジン誘導体 |
| UA74852C2 (en) * | 2000-12-08 | 2006-02-15 | 3M Innovative Properties Co | Urea-substituted imidazoquinoline ethers |
| JP4602667B2 (ja) * | 2001-10-23 | 2010-12-22 | メルク セローノ ソシエテ アノニム | アゾール誘導体および該アゾール誘導体を含有する医薬組成物 |
| GB0211649D0 (en) * | 2002-05-21 | 2002-07-03 | Novartis Ag | Organic compounds |
| AU2003259226A1 (en) | 2002-07-23 | 2004-02-09 | Biogal Gyogyszergyar Rt | Preparation of 1h-imidazo(4,5-c)quinolin-4-amines via1h-imidazo (4,5-c)quinolin-4-phthalimide intermediates |
| PT1539752E (pt) | 2002-07-26 | 2007-05-31 | Teva Gyogyszergyar Zartkoeruen | Preparação de 1h-imidazo [4,5-c] quinolina-4-aminas via novos intermediários imidazo [4,5-c] quinolina-4-ciano e 1h-imidazo [4,5-c] quinolina-4-carboxamida |
| BRPI0413558A (pt) | 2003-08-12 | 2006-10-17 | 3M Innovative Properties Co | compostos contendo imidazo substituìdo por hidroxilamina |
| AU2004268625B2 (en) * | 2003-08-27 | 2011-03-31 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted imidazoquinolines |
| AU2004270201A1 (en) | 2003-09-05 | 2005-03-17 | 3M Innovative Properties Company | Treatment for CD5+ B cell lymphoma |
| EP1668010A2 (en) | 2003-10-01 | 2006-06-14 | Taro Pharmaceuticals U.S.A., Inc. | Method of preparing 4-amino-1h -imidazo(4,5- c )quinolines and acid addition salts thereof |
| AR046046A1 (es) * | 2003-10-03 | 2005-11-23 | 3M Innovative Properties Co | Imidazoquinolinas alcoxi sustituidas. composiciones farmaceuticas. |
| US7544697B2 (en) | 2003-10-03 | 2009-06-09 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridines and analogs thereof |
| ITMI20032121A1 (it) * | 2003-11-04 | 2005-05-05 | Dinamite Dipharma Spa In Forma Abbr Eviata Dipharm | Procedimento per la preparazione di imiquimod e suoi intermedi |
| CA2545825A1 (en) | 2003-11-14 | 2005-06-02 | 3M Innovative Properties Company | Hydroxylamine substituted imidazo ring compounds |
| EP1685129A4 (en) | 2003-11-14 | 2008-10-22 | 3M Innovative Properties Co | OXIMSUBSTITUTED IMIDAZORING CONNECTIONS |
| CA2547020C (en) | 2003-11-25 | 2014-03-25 | 3M Innovative Properties Company | 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier |
| JP2007517035A (ja) | 2003-12-29 | 2007-06-28 | スリーエム イノベイティブ プロパティズ カンパニー | アリールアルケニルおよびアリールアルキニル置換されたイミダゾキノリン |
| EP1699788A2 (en) | 2003-12-30 | 2006-09-13 | 3M Innovative Properties Company | Imidazoquinolinyl, imidazopyridinyl and imidazonaphthyridinyl sulfonamides |
| WO2005094531A2 (en) | 2004-03-24 | 2005-10-13 | 3M Innovative Properties Company | Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines |
| US8017779B2 (en) | 2004-06-15 | 2011-09-13 | 3M Innovative Properties Company | Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines |
| WO2006038923A2 (en) | 2004-06-18 | 2006-04-13 | 3M Innovative Properties Company | Aryl substituted imidazonaphthyridines |
| WO2006065280A2 (en) | 2004-06-18 | 2006-06-22 | 3M Innovative Properties Company | Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods |
| US8026366B2 (en) | 2004-06-18 | 2011-09-27 | 3M Innovative Properties Company | Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines |
| JP5543068B2 (ja) | 2004-12-30 | 2014-07-09 | スリーエム イノベイティブ プロパティズ カンパニー | キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物 |
| EP1831221B1 (en) | 2004-12-30 | 2012-08-08 | 3M Innovative Properties Company | Substituted chiral fused 1,2 imidazo 4,5-c ring compounds |
| AU2006210392A1 (en) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune response modifiers |
| AU2006213746A1 (en) | 2005-02-11 | 2006-08-17 | Coley Pharmaceutical Group, Inc. | Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods |
| EP1869043A2 (en) | 2005-04-01 | 2007-12-26 | Coley Pharmaceutical Group, Inc. | Pyrazolopyridine-1,4-diamines and analogs thereof |
| AU2006232375A1 (en) | 2005-04-01 | 2006-10-12 | Coley Pharmaceutical Group, Inc. | 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases |
| CN101304748A (zh) | 2005-08-22 | 2008-11-12 | 加利福尼亚大学董事会 | Tlr激动剂 |
| EP2700638A1 (en) | 2006-05-31 | 2014-02-26 | The Regents Of the University of California | Purine analogs |
| US7906506B2 (en) | 2006-07-12 | 2011-03-15 | 3M Innovative Properties Company | Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods |
| CN101790380B (zh) | 2007-02-07 | 2013-07-10 | 加利福尼亚大学董事会 | 合成tlr激动剂的缀合物及其应用 |
| EP2009002A1 (en) * | 2007-06-21 | 2008-12-31 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | New process for the manufacture of 1H-imidazo [4,5-c]-quinoline ring systems |
| WO2010088924A1 (en) | 2009-02-06 | 2010-08-12 | Telormedix Sa | Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration |
| KR20110117705A (ko) | 2009-02-11 | 2011-10-27 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 톨-유사 수용체 조정제 및 질병의 치료 |
| US9242980B2 (en) * | 2010-08-17 | 2016-01-26 | 3M Innovative Properties Company | Lipidated immune response modifier compound compositions, formulations, and methods |
| US8728486B2 (en) | 2011-05-18 | 2014-05-20 | University Of Kansas | Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds |
| CA2850932A1 (en) * | 2011-10-04 | 2013-04-11 | Janus Biotherapeutics, Inc. | Novel imidazole quinoline-based immune system modulators |
| WO2014120995A2 (en) | 2013-02-01 | 2014-08-07 | Wellstat Therapeutics Corporation | Amine compounds having anti-inflammatory, antifungal, antiparasitic and anticancer activity |
| CN105189495A (zh) * | 2013-03-15 | 2015-12-23 | 先正达参股股份有限公司 | 新颖的杀微生物剂 |
| ES2538880B1 (es) * | 2013-12-24 | 2016-09-08 | Laboratorios Viñas S.A. | Un procedimiento para obtener 4-amino-1-isobutil-1H-imidazo[4,5-c]quinoleína |
| DK3092256T3 (da) | 2014-01-10 | 2022-06-20 | Birdie Biopharmaceuticals Inc | Forbindelser og sammensætninger til immunterapi |
| CN121243402A (zh) | 2014-07-09 | 2026-01-02 | 博笛生物科技有限公司 | 用于治疗肿瘤的抗-pd-l1组合 |
| RU2722149C1 (ru) * | 2015-09-14 | 2020-05-27 | Пфайзер Инк. | Новые производные имидазо[4,5-c] хинолинов и имидазо[4,5-c][1,5] нафтиридинов в качестве ингибиторов LRRK2 |
| CN106943597A (zh) | 2016-01-07 | 2017-07-14 | 博笛生物科技（北京）有限公司 | 用于治疗肿瘤的抗-egfr组合 |
| CN106943596A (zh) | 2016-01-07 | 2017-07-14 | 博笛生物科技（北京）有限公司 | 用于治疗肿瘤的抗-cd20组合 |
| US10533007B2 (en) | 2016-04-19 | 2020-01-14 | Innate Tumor Immunity, Inc. | NLRP3 modulators |
| KR20180134395A (ko) | 2016-04-19 | 2018-12-18 | 인네이트 튜머 이뮤니티, 인코포레이티드 | Nlrp3 조정제 |
| US11697851B2 (en) | 2016-05-24 | 2023-07-11 | The Regents Of The University Of California | Early ovarian cancer detection diagnostic test based on mRNA isoforms |
| TWI674261B (zh) | 2017-02-17 | 2019-10-11 | 美商英能腫瘤免疫股份有限公司 | Nlrp3 調節劑 |
| CN108794467A (zh) | 2017-04-27 | 2018-11-13 | 博笛生物科技有限公司 | 2-氨基-喹啉衍生物 |
| CA3067268A1 (en) | 2017-06-23 | 2018-12-27 | Birdie Biopharmaceuticals, Inc. | Crystalline resiquimod monosulfate anhydrate and its preparation and uses |
| FR3113287B1 (fr) | 2020-08-07 | 2023-06-23 | Phv Pharma | Procédé industriel de synthèse de l’imiquimod à partir de la quinolèine-2,4-diol applicable à son utilisation pharmaceutique |
| JP2023552993A (ja) * | 2020-12-09 | 2023-12-20 | ウェルスタット セラピューティクス コーポレイション | 抗炎症作用、抗真菌作用、抗寄生虫作用、及び抗がん作用を有するイミダゾキノリン化合物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3700674A (en) * | 1969-04-30 | 1972-10-24 | American Cyanamid Co | 4-alkylamino-3-nitroquinolines |
| IL68495A0 (en) * | 1982-05-03 | 1983-07-31 | Lilly Co Eli | 2-phenylimidazo(4,5-c)pyridines |
-
1984
- 1984-11-13 CA CA000467706A patent/CA1271477A/en not_active Expired - Lifetime
- 1984-11-14 AU AU35402/84A patent/AU581190B2/en not_active Expired
- 1984-11-15 NO NO844565A patent/NO163819C/no not_active IP Right Cessation
- 1984-11-15 DK DK542684A patent/DK164280C/da not_active IP Right Cessation
- 1984-11-15 ES ES537677A patent/ES537677A0/es active Granted
- 1984-11-16 IE IE2952/84A patent/IE57874B1/en not_active IP Right Cessation
- 1984-11-16 EP EP88116137A patent/EP0310950B1/en not_active Expired - Lifetime
- 1984-11-16 NZ NZ210228A patent/NZ210228A/xx unknown
- 1984-11-16 DE DE1999175027 patent/DE19975027I2/de active Active
- 1984-11-16 EP EP84307974A patent/EP0145340B1/en not_active Expired - Lifetime
- 1984-11-16 AT AT84307974T patent/ATE49763T1/de active
- 1984-11-16 DE DE8888116137T patent/DE3486043T2/de not_active Expired - Lifetime
- 1984-11-16 DE DE8484307974T patent/DE3481124D1/de not_active Expired - Lifetime
- 1984-11-16 IL IL84537A patent/IL84537A/xx not_active IP Right Cessation
- 1984-11-16 AT AT88116137T patent/ATE84525T1/de not_active IP Right Cessation
- 1984-11-16 PH PH31451A patent/PH22338A/en unknown
- 1984-11-17 JP JP59243142A patent/JPS60123488A/ja active Granted
- 1984-11-17 KR KR1019840007224A patent/KR900005657B1/ko not_active Expired
-
1987
- 1987-11-19 IL IL84537A patent/IL84537A0/xx unknown
-
1989
- 1989-02-14 AU AU29911/89A patent/AU611997B2/en not_active Expired
- 1989-02-27 NO NO890824A patent/NO165147C/no not_active IP Right Cessation
- 1989-02-27 NO NO890826A patent/NO168705C/no not_active IP Right Cessation
- 1989-02-27 NO NO890823A patent/NO165146C/no not_active IP Right Cessation
- 1989-02-27 NO NO890822A patent/NO165145C/no not_active IP Right Cessation
- 1989-02-27 NO NO890825A patent/NO169437C/no not_active IP Right Cessation
-
1991
- 1991-07-16 DK DK135791A patent/DK169179B1/da not_active IP Right Cessation
- 1991-07-16 DK DK135891A patent/DK164455C/da not_active IP Right Cessation
- 1991-07-16 DK DK136091A patent/DK164451C/da not_active IP Right Cessation
- 1991-07-16 DK DK135991A patent/DK165921C/da not_active IP Right Cessation
- 1991-07-16 DK DK136191A patent/DK164452C/da not_active IP Right Cessation
-
1998
- 1998-12-14 NL NL980041C patent/NL980041I2/nl unknown
- 1998-12-14 NL NL980043C patent/NL980043I1/nl unknown
-
1999
- 1999-07-08 NO NO1999015C patent/NO1999015I1/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR900005657B1 (ko) | 1H-이미다조[4,5-c]퀴놀린 화합물및 그것의 제조방법 | |
| US4698348A (en) | 1H-imidazo[4,5-c]quinolines and their use as bronchodilating agents | |
| US4689338A (en) | 1H-Imidazo[4,5-c]quinolin-4-amines and antiviral use | |
| JP2941336B2 (ja) | １ｈ―イミダゾ〔４，５―ｃ〕キノリン―４―アミン類 | |
| CA2289219C (en) | 1-substituted, 2-substituted 1h-imidazo[4,5-c]quinolin-4-amines | |
| JP3315983B2 (ja) | １−置換 １Ｈ−イミダゾ（４，５−ｃ）キノリン−４−アミン，中間体及び医薬用組成物 | |
| US5605899A (en) | 1-substituted, 2-substituted 1H-imidazo[4,5-c]quinolin-4-amines | |
| KR0180226B1 (ko) | 올레핀 1H-이미다조 [4,5-c] 퀴놀린-4- 아민 | |
| KR20050028047A (ko) | 1ｈ-이미다조[4,5-ｃ]퀴놀린-4-프탈이미드 중간체를 통한1ｈ-이미다조[4,5-ｃ]퀴놀린-4-아민의 제조 | |
| US4124587A (en) | 4-Hydroxy-3-sulfinyl-quinolin-2(1H)-ones | |
| EP0242230A2 (en) | Pyrido [1,2-a] pyrimidine derivatives | |
| NZ241942A (en) | Quinoline derivatives | |
| CS244698B2 (cs) | Způsob výroby v poloze 9 substituovaných derivátů 4-oxo-4H- -pyrido[1,2-a]-pyrimidinu | |
| EP0097468A2 (en) | Thio-naphthotriazoles, methods for producing them and their use in treating allergic diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19841117 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19870928 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19841117 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19900326 Patent event code: PE09021S01D |
|
| G160 | Decision to publish patent application | ||
| PG1605 | Publication of application before grant of patent |
Comment text: Decision on Publication of Application Patent event code: PG16051S01I Patent event date: 19900705 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19901018 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 19901107 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 19901107 End annual number: 3 Start annual number: 1 |
|
| PR1001 | Payment of annual fee |
Payment date: 19930722 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 19940728 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 19950728 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 19960726 Start annual number: 7 End annual number: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 19970731 Start annual number: 8 End annual number: 8 |
|
| PR1001 | Payment of annual fee |
Payment date: 19980730 Start annual number: 9 End annual number: 9 |
|
| PR1001 | Payment of annual fee |
Payment date: 19990729 Start annual number: 10 End annual number: 10 |
|
| PR1001 | Payment of annual fee |
Payment date: 20000729 Start annual number: 11 End annual number: 11 |
|
| PR1001 | Payment of annual fee |
Payment date: 20010728 Start annual number: 12 End annual number: 12 |
|
| PR1001 | Payment of annual fee |
Payment date: 20020726 Start annual number: 13 End annual number: 13 |
|
| PR1001 | Payment of annual fee |
Payment date: 20030724 Start annual number: 14 End annual number: 14 |
|
| FPAY | Annual fee payment |
Payment date: 20040802 Year of fee payment: 15 |
|
| PR1001 | Payment of annual fee |
Payment date: 20040802 Start annual number: 15 End annual number: 15 |
|
| EXPY | Expiration of term | ||
| PC1801 | Expiration of term |